Skip to main navigation Skip to search Skip to main content

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer

  • R. L. Milne
  • , E. L. Goode
  • , Montserrat Garcia-Closas
  • , F. J. Couch
  • , Gianluca Severi
  • , Rebecca Hein
  • , Zachary Fredericksen
  • , Núria Malats
  • , M. P. Zamora
  • , J. I. A. Perez
  • , Javier Benitez
  • , T. Dork
  • , P. Schurmann
  • , J. H. Karstens
  • , P. Hillemanns
  • , A. Cox
  • , I. W. Brock
  • , G. Elliot
  • , S. S. Cross
  • , Sheila Seal
  • C. Turnbull, Anthony Renwick, Nazneen Rahman, C.-Y. Shen, J.-C. Yu, C.-S. Huang, M.-F. Hou, B. G. Nordestgaard, S. E. Bojesen, Charlotte Lanng, G. G. Alnaes, V. Kristensen, A.-L. Borrensen-Dale, J. L. Hopper, G. S. Dite, Carmel Apicella, M. C. Southey, D. Lambrechts, B. T. Yesilyurt, Giuseppe Floris, Karin Leunen, Suleeporn Sangrajrang, Valerie Gaborieau, Paul Brennan, James McKay, Jenny Chang-Claude, Shan Wang-Gohrke, Paolo Radice, Paolo Peterlongo, Siranoush Manoukian, Monica Barile, G. G. Giles, Laura Baglietto, E. M. John, Alexander Miron, S. J. Chanock, Jolanta Lissowska, M. E. Sherman, J. D. Figueroa, N. V. Bogdanova, N. N. Antonenkova, I. V. Zalutsky, Y. I. Rogov, P. A. Fasching, C. M. Bayer, A. B. Ekici, M. W. Beckmann, Hermann Brenner, H. Muller, Volker Arndt, Christa Stegmaier, I. L. Andrulis, J. A. Knight, Gord Glendon, A. M. Mulligan, Arto Mannermaa, Vesa Kataja, V.-M. Kosma, J. M. Hartikainen, Alfons Meindl, Joerg Heil, C. R. Bartram, R. K. Schmutzler, G. D. Thomas, R. N. Hoover, Olivia Fletcher, L. J. Gibson, Isabel Dos Santos Silva, Julian Peto, Stefan Nickels, Dieter Flesch-Janys, Hoda Anton-Culver, Argyrios Ziogas, E. Sawyer, I. Tomlinson, M. Kerin, Nicola Miller, M. K. Schmidt, Annegien Broeks, L. J. Van 'T Veer, Robert A. E. M. Tollenaar, P. D. P. Pharoah, A. M. Dunning, K. A. Pooley, F. Marme, Andreas Schneeweiss, Christof Sohn, Barbara Burwinkel, A. Jakubowska, Jan Lubinski, Katarzyna Jaworska, K. Durda, Daehee Kang, K.-Y. Yoo, D.-Y. Noh, S.-H. Ahn, D. J. Hunter, S. E. Hankinson, Peter Kraft, Sara Lindstrom, X. Chen, Jonathan Beesley, Ute Hamann, Volker Harth, Christina Justenhoven, Robert Winqvist, Katri Pylkas, Arja Jukkola-Vuorinen, Mervi Grip, M. Hooning, Antoinette Hollestelle, R. A. Oldenburg, M. Tilanus-Linthorst, Elza Khusnutdinova, Marina Bermisheva, Darya Prokofieva, Albina Farahtdinova, J. E. Olson, X. Wang, M. K. Humphreys, Q. Wang, Georgia Chenevix-Trench, D. F. Easton
  • Cell Division and Cancer Group
  • University of Melbourne
  • Mayo Clinic
  • Divisions of Molecular Pathology and Cancer Therapeutics
  • Cancer Council Victoria
  • Heidelberg University
  • Gentofte University Hospital
  • KU Leuven– University Hospital Leuven
  • National Cancer Institute of Thailand
  • Intl. Agency for Research on Cancer
  • Ulm University
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
  • IFOM - The FIRC Institute of Molecular Oncology
  • Department of Experimental Oncology
  • Harvard Medical School
  • National Cancer Institute (NCI)
  • M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
  • University Hospital Erlangen
  • Saarland Cancer Registry
  • University of Toronto
  • University of Eastern Finland
  • Kuopio University Hospital
  • Klinikum Rechts der Isar
  • London School of Hygiene and Tropical Medicine
  • University Medical Center Hamburg-Eppendorf
  • University of California, Irvine
  • Galway University Hospital
  • Antoni Van Leeuwenhoek Hospital
  • Pomeranian Medical University in Szczecin
  • Medical University of Warsaw
  • Seoul National University College of Medicine
  • Harvard School of Public Health
  • QIMR Berghofer Medical Research Institute
  • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance
  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
  • University of Tübingen
  • University of Oulu
  • University Hospital of Oulu
  • Josephine Nefkens Institute - JNI
  • Russian Academy of Sciences

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

25 Citations (Scopus)

Abstract

Background: The single-nucleotide polymorphism (SNP) 5p12-rs10941679 has been found to be associated with risk of breast cancer, particularly estrogen receptor (ER)-positive disease. We aimed to further explore this association overall, and by tumor histopathology, in the Breast Cancer Association Consortium. Methods: Data were combined from 37 studies, including 40,972 invasive cases, 1,398 cases of ductal carcinoma in situ (DCIS), and 46,334 controls, all of white European ancestry, as well as 3,007 invasive cases and 2,337 controls of Asian ancestry. Associations overall and by tumor invasiveness and histopathology were assessed using logistic regression. Results: For white Europeans, the per-allele OR associated with 5p12-rs10941679 was 1.11 (95% CI = 1.08-1.14, P = 7 × 10-18) for invasive breast cancer and 1.10 (95% CI = 1.01-1.21, P = 0.03) for DCIS. For Asian women, the estimated OR for invasive disease was similar (OR = 1.07, 95%CI = 0.99-1.15, P = 0.09). Further analyses suggested that the association in white Europeans was largely limited to progesterone receptor (PR)- positive disease (per-allele OR = 1.16, 95% CI = 1.12-1.20, P = 1 × 10-18 vs. OR = 1.03, 95% CI = 0.99-1.07, P = 0.2 for PR-negative disease; Pheterogeneity = 2 × 10 -7); heterogeneity by ER status was not observed (P= 0.2) once PR status was accounted for. The association was also stronger for lower grade tumors [per-allele OR (95% CI) = 1.20 (1.14-1.25), 1.13 (1.09-1.16), and 1.04 (0.99-1.08) for grade 1, 2, and 3/4, respectively; Ptrend = 5 × 10 -7]. Conclusion: 5p12 is a breast cancer susceptibility locus for PR-positive, lower grade breast cancer. Impact: Multicenter fine-mapping studies of this region are needed as a first step to identifying the causal variant or variants.

Original languageEnglish
Pages (from-to)2222-2231
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume20
Issue number10
DOIs
Publication statusPublished - 1 Oct 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • alleles
  • common variants
  • confer susceptibility
  • Externally hosted open access publications with University of Galway authors
  • risk
  • subtypes

Fingerprint

Dive into the research topics of 'Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer'. Together they form a unique fingerprint.

Cite this